Kidney Disease

We work in close partnership with the Broad’s Center for the Development of Therapeutics (CDoT) and several Broad platforms (Genomics, Proteomics, Genetic Perturbation, Metabolomics, Cell Painting), as well as numerous collaborators around the world.  

The team, led by Anna Greka, is deeply focused on: 

Advances in DNA sequencing technology during the past decade have given scientists powerful tools to peer into the genomes of humans and other species. Despite the efficiency and sophistication of these technologies – known as massively parallel, or next-generation, sequencers – some of the genome’s secrets still remain hidden.